Hologic Inc (HOLX) FinancialsHOLXHologic Inc

Hologic Inc (HOLX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Disposables, accounting for 64.3% of total sales, equivalent to $658.40M. Other significant revenue streams include Service and Capital equipment, components and software. Understanding this composition is critical for investors evaluating how HOLX navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Hologic Inc maintains a gross margin of 57.21%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 24.87%, while the net margin is 17.09%. These profitability ratios, combined with a Return on Equity (ROE) of 10.86%, provide a clear picture of how effectively HOLX converts its operational activities into shareholder value.

In the context of the broader market, HOLX competes directly with industry leaders such as ZBH and WST. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, HOLX's gross margin of 57.21% stands against ZBH's 63.30% and WST's 37.74%. Such benchmarking helps identify whether Hologic Inc is trading at a premium or discount relative to its financial performance.

In Q1 2026, revenue increased by 2.54% YoY to $1,047,800,000, but net income dropped by 10.90% YoY to $179,100,000. EPS also declined by 9.20% YoY to 0.79. Gross margin improved slightly by 1.53% YoY to 57.21%. Overall, the financial performance shows mixed results with declining profitability.